Displaying archives for 2014 May:

The Search for Genes That Prevent Disease

Posted by Samantha Powell on May 29th, 2014 |

What can we learn from people with genetic predispositions to a disease who never end up getting sick? The X-Men’s mutations gave them superpowers. Telepathy. Flight. Teleportation. Some scientists believe that there may be some among us who have a superpower in our genes, too—the ability, against all odds, to stay healthy. Finding these people… Read More

LungCAN® Urges Medicare to Cover Cost of Lung Cancer Screening

Posted by Samantha Powell on May 28th, 2014 |

The Center for Medicare and Medicaid Services (CMS) is now considering whether Medicare should cover lung cancer screening for seniors at high risk for the disease. Astonishingly, rejecting scientific evidence that lung cancer screening saves lives, the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) recommended against Medicare covering the cost of this procedure. The… Read More

Pizza and beer ‘blast’ raises money for lung cancer research

Posted by Samantha Powell on May 27th, 2014 |

A Pizza and Beer Blast — a benefit for the Bonnie J. Addario Lung Cancer Foundation — begins at 7 p.m. on Friday, May 30, at the Wilton Riding Club on Riding Club Road. The event is hosted by Cathy Parese and Tricia Hartner, both lung cancer survivors from Wilton. “There are so many people… Read More

Join our Grow for the Cure Campaign this Father’s Day!

Posted by Samantha Powell on May 27th, 2014 |

What is “Grow for the Cure”? Grow for the Cure is a unique website where volunteers register to grow facial hair and people can donate money to their favorite beard style. The brave volunteer will shave his beard to the winning style at the end of his campaign. Grow for the Cure is an affiliate… Read More

ROI Grants a $200,000 Award to Evaluate the Value of Radiation Therapy and Patient Outcomes Among Lung Cancer Patients

Posted by Samantha Powell on May 21st, 2014 |

Date: 1/21/14 Outlet Full Name: News Wise Author: No author http://www.newswise.com/articles/roi-grants-a-200-000-award-to-evaluate-the-value-of-radiation-therapy-and-patient-outcomes-among-lung-cancer-patients?ret=/articles/list&category=medicine&page=1&search%5Bstatus%5D=3&search%5Bsort%5D=date+desc&search%5Bsection%5D=10&search%5Bhas_multimedia%5D= Newswise — Fairfax, Va., January 21, 2014 – The Radiation Oncology Institute (ROI) has selected Christopher G. Slatore, MD, an assistant professor in the division of pulmonary and critical care medicine at the Portland VA Medical Center in Portland, Oregon, and a leader in… Read More

New Data for Gilotrif Shows a Significant Improvement in Overall Survival in Lung Cancer Patients Whose Tumors Have the Most Common EGFR Mutation

Posted by Samantha Powell on May 20th, 2014 |

Date: 5/20/14 Outlet Full Name: Medical News Today Author: No author http://www.medicalnewstoday.com/releases/277021.php Boehringer Ingelheim has announced new overall survival data of two Phase III clinical trials (LUX-Lung 3 and LUX-Lung 6). Patients with advanced non-small cell lung cancer (NSCLC) whose tumors have the most common epidermal growth factor receptor (EGFR) mutation (exon 19 deletion) lived… Read More

Bronchial Gene Test Rules Out Lung Cancer

Posted by Samantha Powell on May 20th, 2014 |

Date: 5/20/14 Outlet Full Name: Med Page Today Author: Crystal Phend http://www.medpagetoday.com/MeetingCoverage/ATS/45872 Gene analysis of the bronchial airway could reduce unnecessary invasive testing for suspected cases of lung cancer, a study suggested. A 17-gene test for normal epithelial cells gathered on bronchoscopy boosted the ability of that procedure to rule out cancer, Duncan Whitney, PhD,… Read More

Genprex Begins Phase 2 Lung Cancer Trial

Posted by Samantha Powell on May 20th, 2014 |

Date: 5/20/14 Outlet Full Name: Drug Discovery and Development Author: No author http://www.dddmag.com/news/2014/05/genprex-begins-phase-2-lung-cancer-trial Genprex Inc. announced that it has enrolled the first patient in a clinical trial evaluating its lead product candidate Oncoprex in combination with erlotinib (Tarceva) for late-stage lung cancer patients. Oncoprex is a targeted biologic incorporating the pan-kinase inhibitor TUSC2, which inhibits… Read More

Next- Generation Sequencing in Lung Cancer

Posted by Samantha Powell on May 20th, 2014 |

Date: 5/20/14 Outlet Full Name: Oncology Live Author: No author http://www.onclive.com/peer-exchange/nsclc-outcomes/Next-Generation-Sequencing-in-Lung-Cancer Panelists: Mark G. Kris, MD, MSKCC; Corey J. Langer, MD, Penn; Benjamin P. Levy, MD, Mount Sinai; Mark A. Socinski, MD, UPMC; Heather A. Wakelee, MD, Stanford Follow link above to watch video Molecular pathology has become an integral part of thoracic oncology, as… Read More

Gene Tests May Improve Lung Cancer: Study

Posted by Samantha Powell on May 20th, 2014 |

Date: 5/20/14 Outlet Full Name: U.S. News Author: No author http://health.usnews.com/health-news/articles/2014/05/20/gene-tests-may-improve-lung-cancer-care-study TUESDAY, May 20, 2014 (HealthDay News) — Testing lung cancer patients’ tumors for various gene mutations may help doctors choose the best treatment, and possibly extend people’s lives, a new study suggests. Experts said the findings, reported in the May 21 Journal of the… Read More